⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14142458 | 0.77 | — | — | |
| SCHEMBL28762363 | 0.74 | — | — | |
| SCHEMBL9021791 | 0.74 | — | — | |
| SCHEMBL2162530 | 0.74 | — | — | |
| SCHEMBL1004302 | 0.72 | — | — | |
| SCHEMBL6112732 | 0.72 | — | — | |
| SCHEMBL9366764 | 0.72 | — | — | |
| SCHEMBL6362114 | 0.72 | — | — | |
| SCHEMBL25565 | 0.71 | — | — | |
| SCHEMBL4425211 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103664591-A | Novel benzendiol derivative compound and cosmetic composition utilizing the same | ACT CO LTD | 2014-03-26 | — | — | CN | claimed |
| US-8486892-B2 | Blood coagulation factor inhibitors | NOVO NORDISK HEALTH CARE AG (CH) | 2013-07-16 | — | — | US | claimed |
| US-20110269758-A1 | NAPHTHYRIDINONES AS PROTEIN KINASE INHIBITORS | MERCK PATENT GMBH (DE) | 2011-11-03 | — | — | US | claimed |
| JP-2011526912-A | — | — | 2011-10-20 | — | — | JP | claimed |
| CN-102083831-A | Naphthyridininones as AURORA kinase inhibitors | MERCK SERONO SA | 2011-06-01 | — | — | CN | claimed |
| EP-2291376-A2 | NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS | Merck Patent GmbH (DE) | 2011-03-09 | — | — | EP | claimed |
| US-20110003752-A1 | New Blood Coagulation Factor Inhibitors | NOVO NORDISK HEALTH CARE A/G (CH) | 2011-01-06 | — | — | US | claimed |
| EP-2235042-A1 | NEW BLOOD COAGULATION FACTOR INHIBITORS | Novo Nordisk Health Care AG (CH) | 2010-10-06 | — | — | EP | claimed |
| US-20100099880-A1 | Alternate Process for Remifentanil Preparation | MALLINCKRODT INC. | 2010-04-22 | — | — | US | claimed |
| WO-2010002779-A2 | NAPHTHYRIDININONES AS AURORA KINASE INHIBITORS | MERCK SERONO S.A. (CH) | 2010-01-07 | — | — | WO | claimed |
| EP-2125730-A2 | NEW PROCESS FOR REMIFENTANIL SYNTHESIS | Mallinckrodt Inc. (US) | 2009-12-02 | — | — | EP | claimed |
| WO-2009092758-A1 | NEW BLOOD COAGULATION FACTOR INHIBITORS | NOVO NORDISK HEALTH CARE AG (DK) | 2009-07-30 | — | — | WO | claimed |
| EP-2081899-A2 | ALTERNATE PROCESS FOR REMIFENTANIL PREPARATION | Mallinckrodt Inc. (US) | 2009-07-29 | — | — | EP | claimed |
| WO-2008066708-A2 | NEW PROCESS FOR REMIFENTANIL SYNTHESIS | MALLINCKRODT INC. (US) | 2008-06-05 | — | — | WO | claimed |
| WO-2008045192-A2 | ALTERNATE PROCESS FOR REMIFENTANIL PREPARATION | MALLINCKRODT INC. (US) | 2008-04-17 | — | — | WO | claimed |
| WO-2024029475-A1 | WAVELENGTH CONVERSION FILM FORMING COMPOSITION | 日産化学株式会社 | 2024-02-08 | — | — | WO | disclosed |
| US-10326138-B2 | Charge storage material, electrode active material and secondary battery | WASEDA UNIVERSITY (JP) | 2019-06-18 | — | — | US | disclosed |
| US-4513037-A | Multilayered hollow polycarbonate containers | GENERAL ELECTRIC COMPANY (US) | 1985-04-23 | — | — | US | disclosed |
| US-4294953-A | Process for preparing a branched polycarbonate | GENERAL ELECTRIC COMPANY (US) | 1981-10-13 | — | — | US | disclosed |
| US-4071563-A | Manufacture of pent-4-en-1-al | BASF AKTIENGESELLSCHAFT (DT) | 1978-01-31 | — | — | US | disclosed |